June 28 (Reuters) - The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby ...
Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for ...
For Q2, according to Seeking Alpha, analysts are expecting normalized EPS of $1.28, GAAP EPS of $0.97, and $12.52bn of ...
Abbott Laboratories is one of the world's leading medical device makers. It routinely develops and markets newer products, and its portfolio boasts dozens of patented devices that generate consistent ...
Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results